The Economic Burden of Malaria Inpatients and Its Determinants During China's Elimination Stage.

Fangfei Chen,Xiaoyu Chen,Peng Gu,Xiaodong Sang,Ruijun Wu,Miaomiao Tian,Yisheng Ye,Chengxu Long,Ghose Bishwajit,Lu Ji,Da Feng,Lei Yang,Shangfeng Tang
DOI: https://doi.org/10.3389/fpubh.2022.994529
IF: 5.2
2022-01-01
Frontiers in Public Health
Abstract:Background:Malaria burden is still worrisome, while empirical evidence from malaria-eliminated countries including China may provide inspiration for the world.Objective:This study aimed to investigate China's malaria hospitalization costs and explore its determinants.Methods:Stratified multistage sampling across provincial, municipal, and county hospitals was conducted in 2017. All the malaria medical records were retrieved from 2014 to 2016 in 70 hospitals. Parametric and non-parametric methods were employed to estimate hospitalization costs, and the non-parametric bootstrap was used to compare hospitalization costs among sample areas and assessed the uncertainty of its differences. Quantile regressions were conducted to identify the determinants of hospitalization costs.Results:The median hospitalization costs of 1633 malaria inpatients were 628 USD. Medication and laboratory tests accounted for over 70% of total expenditure. The median reimbursement rate was 41.87%, and this number was even lower in higher-level hospitals (<35%) and among the New Rural Cooperative Medical Scheme (<40%). Finally, health insurance type, hospital tier, clinical units, unknown fever, and comorbidity were the main determinants of hospitalization costs.Conclusion:The disparity of health protection for malaria hospitalization between rural and urban areas was noteworthy. Equivocal diagnosis and comorbidity are contributors of high cost as well. A reasonable payment system and enhanced capacities to treat malaria in a cost-effective way are suggested to reassure malaria economic burden.
What problem does this paper attempt to address?